Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Odaily Noon News

Odaily Noon News

Odaily星球日报Odaily星球日报2026/03/26 05:31
Show original

1. Trump has informed aides that he hopes to end the Iran war as soon as possible;

2. Circle has unfrozen one of the 16 blacklisted USDC wallets;

3. Citi: Investors are overly optimistic about a swift resolution to the US-Iran issue;

4. The total net inflow for Bitcoin spot ETFs yesterday was $7.8069 million, with only the Fidelity ETF FBTC recording a net inflow;

5. The total net outflow for Ethereum spot ETFs yesterday was $8.5074 million, marking six consecutive days of net outflow;

6. Listed company Tron: The TRX treasury holds more than 688.5 million tokens, with an additional 160,800 TRX acquired today;

7. Federal Reserve advisor: Waller may need five years to reduce the Fed's balance sheet;

8. The founder of Distributed Capital has publicly solicited clues regarding the $42 million theft from a personal wallet in 2022, with a bounty reward of 10%-20%;

9. Hyperliquid BTC's largest short position closed 1,000 BTC at a loss of $2.345 million;

10. Most sectors of the crypto market increased, with the Meme sector up 5.09%; only GameFi and PayFi sectors declined.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks